Elder Pharmaceuticals Ltd.
NSE: ELDERPHARM | BSE: 532322
₹38.00
₹1.80
(4.97%)
As on 12-Sep-2016IST
Market cap
₹78 Cr
Revenue (TTM)
₹633 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-80 Cr
-
ROE
-0.8 %
-
ROCE
15.1 %
-
Industry P/E
42.46
-
EV/EBITDA
-1.9
-
Debt to Equity
0.6
-
Book Value
₹--
-
EPS
₹-220.7
-
Face value
10
-
Shares outstanding
20,536,936
10 Years Aggregate
CFO
₹1,393.76 Cr
EBITDA
₹1,065.49 Cr
Net Profit
₹499.74 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Elder Pharmaceuticals
| -49.2 | 27.1 | 60.7 | -62.3 | -51.8 | -37.4 | -19.5 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
BSE Healthcare#
| 10.2 | 1.2 | 12.0 | 10.9 | 24.0 | 14.1 | 12.4 |
|
Company
|
2015
|
2014
|
|---|---|---|
|
Elder Pharmaceuticals
| -40.3 | -59.3 |
|
BSE Sensex
| -5.0 | 29.9 |
|
BSE Healthcare
| 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Elder Pharmaceuticals
|
38.0 | 78.0 | 633.4 | -79.9 | -39.9 | -61.4 | -- | 0.1 |
| 3,246.2 | 26,239.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 73.7 | 15.9 | |
| 405.9 | 15,532.2 | 2,268.6 | 150.1 | 10.6 | 5.4 | 86.7 | 4.0 | |
| 786.9 | 19,328.2 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.5 | 3.8 | |
| 966.4 | 15,295.8 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.4 | 2.2 | |
| 1,608.6 | 18,431.0 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 158.9 | 21,088.6 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.6 | |
| 1,361.8 | 22,380.4 | 1,284.3 | 134.4 | -- | 30.7 | 90.7 | 17.4 | |
| 440.8 | 17,700.9 | 3,738.7 | 316.7 | 12.5 | 7.5 | 55.9 | 3.7 | |
| 2,011.1 | 32,377.4 | 3,373.0 | 199.0 | 12.6 | 5.9 | 152 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
2 min read•By Research Desk
About Elder Pharmaceuticals
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1983
-
Chairman
--
-
Managing Director
Alok Jagdish Saxena
-
Group
Elder
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
Appointment of Additional Directors
Shareholding Pattern for September 30, 2015
31-Dec-2015No News & Announcements are available.
FAQs for Elder Pharmaceuticals
What is the current share price of Elder Pharmaceuticals Ltd Today?
The share price of Elder Pharmaceuticals Ltd is ₹38.00 (BSE) and ₹82.50 (NSE) as of 12-Sep-2016 IST. Elder Pharmaceuticals Ltd has given a return of -51.84% in the last 3 years.
What is the current PB & PE ratio of Elder Pharmaceuticals Ltd?
Since, TTM earnings of Elder Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Elder Pharmaceuticals Ltd is 0.12 times as on 12-Sep-2016, a 97 discount to its peers’ median range of 3.81 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2014
|
0.00
|
0.58
|
|
2012
|
9.62
|
0.99
|
|
2011
|
12.47
|
1.27
|
|
2010
|
13.68
|
1.41
|
|
2009
|
6.57
|
1.04
|
What is the 52 Week High and Low of Elder Pharmaceuticals Ltd?
The 52-week high and low of Elder Pharmaceuticals Ltd are Rs -- and Rs -- as of 19-Jun-2026.
What is the market cap of Elder Pharmaceuticals Ltd?
Elder Pharmaceuticals Ltd has a market capitalisation of ₹ 78 Cr as on 12-Sep-2016. As per SEBI classification, it is a company.
Should I invest in Elder Pharmaceuticals Ltd?
Before investing in Elder Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.